Impact of primary PCI volume on hospital mortality in STEMI patients: does time-to-presentation matter?

[1]  Procedure volume and outcome: you should take into account each hospital. , 2011, Journal of the American College of Cardiology.

[2]  Giulio Guagliumi,et al.  When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials. , 2010, Journal of the American College of Cardiology.

[3]  E. Livingston,et al.  Procedure volume as a predictor of surgical outcomes. , 2010, JAMA.

[4]  W. Kremers,et al.  Survival differences following lung transplantation among US transplant centers. , 2010, Journal of the American Medical Association (JAMA).

[5]  S. Normand,et al.  Hospital volume and 30-day mortality for three common medical conditions. , 2010, The New England journal of medicine.

[6]  S. de Servi,et al.  Prognostic implications of ST-segment elevation resolution in patients with ST-segment elevation acute myocardial infarction treated with primary or facilitated percutaneous coronary intervention. , 2010, The American journal of cardiology.

[7]  R. Smalling.  Ischemic time: the new gold standard for ST-segment elevation myocardial infarction care. , 2009, Journal of the American College of Cardiology.

[8]  C. Catalano,et al.  Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. , 2009, Journal of the American College of Cardiology.

[9]  Deepak L. Bhatt,et al.  Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes. , 2009, JAMA.

[10]  E. Antman,et al.  Development of Systems of Care for ST-Elevation Myocardial Infarction Patients , 2007 .

[11]  W. Weaver,et al.  Development of systems of care for ST-elevation myocardial infarction patients: the primary percutaneous coronary intervention (ST-elevation myocardial infarction-receiving) hospital perspective. , 2007, Circulation.

[12]  H. Krumholz,et al.  Development of Systems of Care for ST-Elevation Myocardial Infarction Patients: Gaps, Barriers, and Implications , 2007, Circulation.

[13]  R. Gibbons,et al.  Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial). , 2007, The American journal of cardiology.

[14]  G. Schuler,et al.  Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging. , 2006, European heart journal.

[15]  Harlan M Krumholz,et al.  Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. , 2006, Journal of the American College of Cardiology.

[16]  B. Brodie,et al.  Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms. , 2006, Journal of the American College of Cardiology.

[17]  M. Morice,et al.  Is the volume-outcome relation still an issue in the era of PCI with systematic stenting? Results of the greater Paris area PCI registry. , 2006, European heart journal.

[18]  G. Filippatos,et al.  Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology. , 2005, European heart journal.

[19]  Samin K. Sharma,et al.  Volume-Outcome Relationships for Percutaneous Coronary Interventions in the Stent Era , 2005, Circulation.

[20]  B. Gersh,et al.  Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? , 2005, JAMA.

[21]  E. Antman,et al.  Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction. , 2004, Journal of the American College of Cardiology.

[22]  J. Boura,et al.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials , 2022 .

[23]  J. Rumsfeld,et al.  Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. , 2000, JAMA.

[24]  W. Rogers,et al.  The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. , 2000, The New England journal of medicine.

[25]  G. Coffman,et al.  Predicting In-Hospital Mortality: A Comparison of Severity Measurement Approaches , 1992, Medical care.

[26]  R. Jennings,et al.  The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. , 1979, Laboratory investigation; a journal of technical methods and pathology.

[27]  H. Akaike.  A new look at the statistical model identification , 1974 .